Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

Stem Cell Treatment for Dry Age-Related Macular Degeneration Entering Clinical Trial Phase

Posted by Kelsey StemSave on Nov 9, 2012 5:00:16 AM

 

 

 

 

 

A Phase I/II clinical trial to treat dry age-related macular degeneration (Dry-AMD) is being conducted by StemCells, Inc. Dry-AMD is the most common type of macular degeneration and affects 90% of patients with the condition. It is a chronic eye disease that causes vision loss in the center of the field of vision and is the major cause of blindness and visual impairment in adults older than 50.

Read More

Topics: Phase III, neural stem cells, stemsaveblog, clinical trials, dry age-related macular degeneration, Stemcells, Phase I/II clinical trials, clinical trial, Dry AMD, StemCells Inc., AMD

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Posts by Topic

see all